Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting (2019)
- Authors:
- USP affiliated authors: STEINER, ALEXANDRE ALARCON - ICB ; ARAUJO, GABRIEL LIMA BARROS DE - FCF ; LOTUFO, LETICIA VERAS COSTA - ICB ; LOPES, LUCIANA BIAGINI - ICB ; MATOS, JENYFFER KELLY ROCHA DE - ICB ; DARTORA, VANESSA FRANCO CARVALHO - ICB ; SALATA, GIOVANNA CASSONE - ICB ; FERNANDEZ, SANDRA COSTA - ICB
- Unidades: ICB; FCF
- DOI: 10.1016/j.ijpharm.2019.118460
- Subjects: FARMACOLOGIA; IMUNOLOGIA; NEOPLASIAS MAMÁRIAS; CITOTOXICIDADE IMUNOLÓGICA; QUITOSANA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Pharmaceutics
- ISSN: 1873-3476
- Volume/Número/Paginação/Ano: v. 567, art. 118460, 13 p., 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: unspecified-oa
-
ABNT
DARTORA, Vanessa Franco Carvalho et al. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, v. 567, p. 13 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2019.118460. Acesso em: 06 maio 2025. -
APA
Dartora, V. F. C., Salata, G. C., Matos, J. K. R. de, Fernandez, S. C., Chorilli, M., Steiner, A. A., et al. (2019). Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting. International Journal of Pharmaceutics, 567, 13 . doi:10.1016/j.ijpharm.2019.118460 -
NLM
Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Costa-Lotufo LV, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2025 maio 06 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460 -
Vancouver
Dartora VFC, Salata GC, Matos JKR de, Fernandez SC, Chorilli M, Steiner AA, Araujo GLB de, Silveira ER, Costa-Lotufo LV, Lopes LB. Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting [Internet]. International Journal of Pharmaceutics. 2019 ; 567 13 .[citado 2025 maio 06 ] Available from: https://doi.org/10.1016/j.ijpharm.2019.118460 - Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration
- Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment
- Bioresponsive nanostructured systems for sustained naltrexone release and treatment of alcohol use disorder: development and biological evaluation
- Improvement of cutaneous delivery of methylene blue by liquid crystals
- Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment
- Development of a method for quantitative determination of the cytotoxic agent piplartine (piperlongumine) in multiple skin layers
- Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer
- Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models
- A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue
- Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide
Informações sobre o DOI: 10.1016/j.ijpharm.2019.118460 (Fonte: oaDOI API)
Download do texto completo
Tipo | Nome | Link | |
---|---|---|---|
2960731_Postprint.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas